Idexx Labs (IDXX) Tops Q3 EPS by 1c; Raises FY11 Outlook; Guides FY12
Get Alerts IDXX Hot Sheet
Price: $560.38 -1.13%
EPS Growth %: +15.5%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +15.5%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Idexx Laboratories, Inc. (NASDAQ: IDXX) reported Q3 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $301 million versus the consensus estimate of $294.88 million.
Idexx Laboratories, Inc. sees FY2011 EPS of $2.71-$2.74, versus prior guidance of $2.68-$2.73 and the consensus of $2.72. Idexx Laboratories, Inc. sees FY2011 revenue of $1.215 billion, versus prior guidance of $1.205-$1.215 billion and the consensus of $1.21 billion.
Idexx Laboratories, Inc. sees FY2012 EPS of $3.00-$3.10, versus the consensus of $3.06. Idexx Laboratories, Inc. sees FY2012 revenue of $1.295-$1.315 billion, versus the consensus of $1.30 billion.
Idexx Laboratories, Inc. sees FY2011 EPS of $2.71-$2.74, versus prior guidance of $2.68-$2.73 and the consensus of $2.72. Idexx Laboratories, Inc. sees FY2011 revenue of $1.215 billion, versus prior guidance of $1.205-$1.215 billion and the consensus of $1.21 billion.
Idexx Laboratories, Inc. sees FY2012 EPS of $3.00-$3.10, versus the consensus of $3.06. Idexx Laboratories, Inc. sees FY2012 revenue of $1.295-$1.315 billion, versus the consensus of $1.30 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share